Control groups matter in immersive virtual reality therapy trials

Virtual Placebo: a scoping review of control conditions in randomized controlled trials of psychological immersive virtual reality interventions

Human-Computer Interaction

Summary

Studies are testing virtual reality (VR) to help with psychological treatments. This paper found many tests compare VR therapy to usual treatments without using a similar VR experience as a control. The authors warn that this can make VR look more effective than it really is. They suggest using a 'virtual placebo' control in future studies to better understand what parts of VR treatments actually work.

What this means in practice

  • For clinical trial designers: Improve VR therapy trials by including immersive virtual placebo controls to separate device effects from treatment effects.
  • For virtual reality developers: Develop control VR experiences that serve as placebos to support more accurate testing of therapeutic VR content.

A survey. It maps existing work.

Authors

Madis Vasser, Mary-Ann Kubre, Kadi Tulver, Jaan Aru

Abstract

Research on immersive virtual reality (IVR) as a therapeutic tool is growing rapidly, with randomized controlled trials (RCTs) now commonplace. Yet the control conditions in many of these studies that claim strong specific IVR effects vary from usual care to active immersive experiences, making it difficult to draw clinically meaningful conclusions. We conducted a scoping review of recent literature on psychological IVR interventions to assess the main forms of control conditions used and their relations to study outcomes. In this paper, we make the case that most of the recent RCTs studying the effects of specific IVR interventions compare active immersive VR to usual care with no multimedia component. This can lead to strong yet potentially misleading study outcomes and can potentially inflate the IVR interventions' effect. Namely, the lack of an appropriate immersive control condition may risk misattributing general effects of VR devices to the specific content of the intervention. In this review, we discuss the implications of these design choices and propose strategies for including a suitable "virtual placebo" condition to improve the methodological rigor and interpretability of results.